Effects of Ublituximab on Motor Functions in Multiple Sclerosis

Clinical trial NCT06629428 · RECRUITING

Trial details

NCT number: NCT06629428
Sponsor: Georgia State University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis (MS) - Relapsing-remitting

Start date: 2025-11-13
Primary completion: 2026-06-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.